Actinic cheilitis – European Clinical Trials Information Network https://clinicaltrials.eu Bridging Patients with Clinical Trials Fri, 12 Jun 2026 10:29:00 +0000 en-US hourly 1 https://wordpress.org/?v=7.0 https://clinicaltrials.eu/wp-content/uploads/2024/12/cropped-EU_icon-32x32.png Actinic cheilitis – European Clinical Trials Information Network https://clinicaltrials.eu 32 32 Study on the Tolerability and Effectiveness of Tirbanibulin for Patients with Actinic Cheilitis https://clinicaltrials.eu/trial/study-on-the-tolerability-and-effectiveness-of-tirbanibulin-for-patients-with-actinic-cheilitis/ Wed, 29 Apr 2026 14:23:55 +0000 https://clinicaltrials.eu/trial/study-on-the-tolerability-and-effectiveness-of-tirbanibulin-for-patients-with-actinic-cheilitis/ This clinical trial is focused on studying Actinic Cheilitis, a condition that affects the lips, often due to prolonged sun exposure. The trial will explore the use of a treatment called Tirbanibulin, which is available as an ointment under the name Klisyri 10 mg/g ointment. The purpose of the study is to determine how well this ointment works and how well it is tolerated by patients with Actinic Cheilitis.

Participants in the study will apply the Tirbanibulin ointment to the affected area on their lips for a period of five days. The study will then monitor the participants over several weeks to assess the healing process. The main goal is to see if the affected area on the lips is completely healed eight weeks after the treatment. The study will also look at how much the affected area has reduced in size and gather feedback from participants about their experience with the treatment.

Throughout the study, researchers will also evaluate any local skin reactions and overall oral health. They will use various methods to ensure accurate diagnosis and track any side effects that may occur. The study aims to provide valuable insights into the effectiveness of Tirbanibulin for treating Actinic Cheilitis and improve understanding of this condition.

]]>